1. Home
  2. ELTX vs EDRY Comparison

ELTX vs EDRY Comparison

Compare ELTX & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$1.90

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo EuroDry Ltd.

EDRY

EuroDry Ltd.

HOLD

Current Price

$43.55

Market Cap

72.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
EDRY
Founded
2011
2018
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
72.8M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
ELTX
EDRY
Price
$1.90
$43.55
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$13.67
★ $45.33
AVG Volume (30 Days)
★ 258.8K
115.6K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 39.29
N/A
EPS
N/A
★ N/A
Revenue
★ $2,301,000.00
N/A
Revenue This Year
N/A
$40.95
Revenue Next Year
N/A
$8.53
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.44
$12.08
52 Week High
$16.00
$73.07

Technical Indicators

Market Signals
Indicator
ELTX
EDRY
Relative Strength Index (RSI) 48.08 39.69
Support Level $1.74 $18.48
Resistance Level $1.97 $53.93
Average True Range (ATR) 0.15 5.01
MACD 0.04 -1.20
Stochastic Oscillator 79.63 10.45

Price Performance

Historical Comparison
ELTX
EDRY

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

Share on Social Networks: